首页> 外国专利> METHOD FOR ENDOVITREAL REMOVAL OF CHOROID MELANOMA WITH PREVENTION OF METASTASIS AND THROMBOEMBOLISM

METHOD FOR ENDOVITREAL REMOVAL OF CHOROID MELANOMA WITH PREVENTION OF METASTASIS AND THROMBOEMBOLISM

机译:预防转移和血栓栓塞去除胆囊黑素瘤的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to ophthalmology. For the treatment of choroid melanoma (CM) by its endovitreal removal, subtotal vitrectomia, retinotomy, coagulation around visible macroscopically base CM, removal of CM from its apex to base with formation of surgical colobolism within visible macroscopically boundaries of healthy tissues, endolaser coagulation (ELC) on surface of scleral bed after removal of CM, retinopexy by ELC along retinotomy margin followed by vitreous cavity tamponade with silicone oil, adjuvant BT with radionuclide Ruthenium-106. First, a conjunctival is incised in 3 mm from the limb, the Tenon's membrane is separated along the whole perimeter, the sclera and vorticose veins are carefully examined. In the absence of extraocular propagation of CM, one vorticose or two vortical veins are blocked, the ampoule or ampoule of which are found in the quadrant or quadrants of CM localization at a distance of at least 2 cm from the venous/vein outlet from the sclera. Subtotal vitrectomy is performed using instruments 25 G, complete tamponade of the VP is applied with a perfluororganic compound with creation of increased intraocular pressure to 50 mm Hg, coagulation around the visible macroscopically CM base is performed by diathermocoagulation, the retinotomy is performed along a diathermocoagulation boundary with the subsequent resectionectomy of the obtained area above the CM; additional 1 mm thick layer of surrounding tissues is additionally resected with a vitreous cutter at frequency of 6000 cuts/min along the entire perimeter of the formed colophony.;EFFECT: method enables complete endovitreal removal of CM with maximum preservation of healthy functionally significant surrounding tissues, reduced dissemination of tumor cells in the vitreal cavity.;1 cl, 1 ex
机译:技术领域本发明涉及眼科。对于脉络膜黑色素瘤(CM)的治疗,方法是通过玻璃体腔内切除术,小玻璃体切除术,视网膜切开术,可见肉眼可见的CM周围的凝结,将CM从其根尖去除到根基,并在健康组织的肉眼可见的宏观边界内形成外科手术代谢,进行激光内凝(去除CM后巩膜床表面的ELC),沿视网膜切开术边缘通过ELC进行视网膜镜检查,然后用硅油进行玻璃体腔填塞,并用放射性核素Ru-nium-106辅助BT。首先,在距肢体3 mm处切开结膜,将腱膜沿整个周缘分开,仔细检查巩膜和旋涡静脉。在不存在CM的眼外传播的情况下,一个或两个涡状静脉被阻塞,其安瓿或安瓿在CM定位的四分之一或四分之一象限中,离静脉/静脉出口至少2 cm巩膜。使用25 G仪器进行玻璃体次全切术,使用全氟有机化合物对VP进行完全填塞,从而将眼内压增至50 mm Hg,通过透热凝结在可见的宏观CM基部周围进行凝结,并通过透热凝结进行切开切开术与在CM上方获得的区域进行后续切除术的边界;另外,用玻璃体切割器沿形成的树脂的整个周长以6000次切割/分钟的频率切除另外1毫米厚的周围组织层。效果:该方法能够彻底清除内膜,从而最大程度地保留健康的功能重要的周围组织,减少了玻璃体腔内肿瘤细胞的扩散。; 1 cl,1 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号